Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Lilly
Biotech

Lilly's $2.3B Ajax drug works ‘right out of the gate’

The early data showed the novel JAK2 inhibitor “started working right out of the gate, with a good safety profile,” Lilly’s Jake Van Naarden said.
Angus Liu Jun 13, 2026 11:15am
Bull market

Biotech IPOs here to stay after another record-breaking listing

Jun 12, 2026 11:00am
Biotech value creation at an inflection point

Biotech value creation at an inflection point

Brought to you by Lumanity
A blue-toned graphic showing assorted pills and capsules scattered across a close-up of a 100 bill with Benjamin Franklin

Ipsen R&D chief on pipeline discipline and 2026 milestones

Jun 12, 2026 9:57am
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Perrigo CEO ousted over ‘personal conduct’—Chutes & Ladders

Jun 12, 2026 8:30am